RxDoctor Payments Data

Heather Ballard, APRN

Nurse Practitioner · Mayfield, KYNPI 1538615570

Payments from drug & device makers

$6,515in general payments, 2019–2025

Across 398 payments — averaging $16.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • AbbVie$1K
  • Johnson & Johnson$1K
  • Ironwood Pharmaceuticals, Inc$389
  • Takeda Pharmaceuticals U.S.A., Inc.$301
  • Gilead$281
  • plus $2K from 21 others

What the payments were for

  • Food & beverage$6,498100%
  • Education$180%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,515 in reported general payments places this provider in the 90th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$41,078
Medicare patients
260
Services billed
434

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab21$168,402
LinzessLinaclotide102$63,683
XifaxanRifaximin19$56,588
PentasaMesalamine14$30,231
Mesalamine ErMesalamine46$19,888
CreonLipase/Protease/Amylase17$18,561
Sucralfate125$7,458
Dexlansoprazole DrDexlansoprazole49$6,326
Omeprazole412$2,935
Lubiprostone22$2,753
Colestipol Hcl27$2,258
Pantoprazole Sodium198$1,867
Ursodiol16$1,866
Dicyclomine Hcl112$1,646
Esomeprazole Magnesium41$1,210

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Creon$1,238$82,244119 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$1,328$56,58819 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Mayfield

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →